Stay updated on Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.

Latest updates to the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, indicating a minor update to the page template and metadata.SummaryDifference0.0%

- Check28 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3; there are no changes to study content or functionality.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior notice for Revision: v3.4.1; these are administrative updates to the site.SummaryDifference0.3%

- Check64 days agoChange DetectedAdded a site-wide notice regarding a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a Show glossary feature and updated metadata labels, including Last Update Submitted that Met QC Criteria and No FEAR Act Data, and changed the Revision to v3.4.0.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page reflects a minor site revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.